Report Detail
Global Tegafur,Gimeracil and Oteracil Porassium Capsules Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4719528 |
- 29 June, 2026 |
- Global |
- 70 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Tegafur,Gimeracil and Oteracil Porassium Capsules market size was valued at US$ 2178 million in 2025 and is forecast to a readjusted size of US$ 15100 million by 2032 with a CAGR of 32.2% during review period.
Tegafur,Gimeracil and Oteracil Porassium Capsules (S-1 capsules) are an oral anti-tumor medication belonging to the fluoropyrimidine class of chemotherapeutic agents. Its primary components are tegafur, gimeracil, and oteracil potassium, which work synergistically to enhance anti-cancer efficacy while reducing side effects. This drug is commonly used for the treatment of gastrointestinal cancers (such as gastric cancer and colorectal cancer) and other solid tumors.
This report is a detailed and comprehensive analysis for global Tegafur,Gimeracil and Oteracil Porassium Capsules market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Channel. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Tegafur,Gimeracil and Oteracil Porassium Capsules market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
Global Tegafur,Gimeracil and Oteracil Porassium Capsules market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
Global Tegafur,Gimeracil and Oteracil Porassium Capsules market size and forecasts, by Type and by Channel, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2021-2032
Global Tegafur,Gimeracil and Oteracil Porassium Capsules market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Tegafur,Gimeracil and Oteracil Porassium Capsules
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Tegafur,Gimeracil and Oteracil Porassium Capsules market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Taiho Pharmaceutical, Jiangsu Hengrui Pharmaceuticals, Qilu Pharmaceutical, Shandong New Era Pharmaceutical, Yangtze River Pharmaceutical Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Tegafur,Gimeracil and Oteracil Porassium Capsules market is split by Type and by Channel. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Channel in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
20mg
25mg
Market segment by Channel
Hospitals
Drug Stores
Major players covered
Taiho Pharmaceutical
Jiangsu Hengrui Pharmaceuticals
Qilu Pharmaceutical
Shandong New Era Pharmaceutical
Yangtze River Pharmaceutical Group
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tegafur,Gimeracil and Oteracil Porassium Capsules product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Tegafur,Gimeracil and Oteracil Porassium Capsules, with price, sales quantity, revenue, and global market share of Tegafur,Gimeracil and Oteracil Porassium Capsules from 2021 to 2026.
Chapter 3, the Tegafur,Gimeracil and Oteracil Porassium Capsules competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tegafur,Gimeracil and Oteracil Porassium Capsules breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Channel, with sales market share and growth rate by Type, by Channel, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Tegafur,Gimeracil and Oteracil Porassium Capsules market forecast, by regions, by Type, and by Channel, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Tegafur,Gimeracil and Oteracil Porassium Capsules.
Chapter 14 and 15, to describe Tegafur,Gimeracil and Oteracil Porassium Capsules sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Tegafur,Gimeracil and Oteracil Porassium Capsules Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 20mg
- 1.3.3 25mg
- 1.4 Market Analysis by Channel
- 1.4.1 Overview: Global Tegafur,Gimeracil and Oteracil Porassium Capsules Consumption Value by Channel: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospitals
- 1.4.3 Drug Stores
- 1.5 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Market Size & Forecast
- 1.5.1 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Quantity (2021-2032)
- 1.5.3 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Taiho Pharmaceutical
- 2.1.1 Taiho Pharmaceutical Details
- 2.1.2 Taiho Pharmaceutical Major Business
- 2.1.3 Taiho Pharmaceutical Tegafur,Gimeracil and Oteracil Porassium Capsules Product and Services
- 2.1.4 Taiho Pharmaceutical Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Taiho Pharmaceutical Recent Developments/Updates
- 2.2 Jiangsu Hengrui Pharmaceuticals
- 2.2.1 Jiangsu Hengrui Pharmaceuticals Details
- 2.2.2 Jiangsu Hengrui Pharmaceuticals Major Business
- 2.2.3 Jiangsu Hengrui Pharmaceuticals Tegafur,Gimeracil and Oteracil Porassium Capsules Product and Services
- 2.2.4 Jiangsu Hengrui Pharmaceuticals Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
- 2.3 Qilu Pharmaceutical
- 2.3.1 Qilu Pharmaceutical Details
- 2.3.2 Qilu Pharmaceutical Major Business
- 2.3.3 Qilu Pharmaceutical Tegafur,Gimeracil and Oteracil Porassium Capsules Product and Services
- 2.3.4 Qilu Pharmaceutical Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Qilu Pharmaceutical Recent Developments/Updates
- 2.4 Shandong New Era Pharmaceutical
- 2.4.1 Shandong New Era Pharmaceutical Details
- 2.4.2 Shandong New Era Pharmaceutical Major Business
- 2.4.3 Shandong New Era Pharmaceutical Tegafur,Gimeracil and Oteracil Porassium Capsules Product and Services
- 2.4.4 Shandong New Era Pharmaceutical Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Shandong New Era Pharmaceutical Recent Developments/Updates
- 2.5 Yangtze River Pharmaceutical Group
- 2.5.1 Yangtze River Pharmaceutical Group Details
- 2.5.2 Yangtze River Pharmaceutical Group Major Business
- 2.5.3 Yangtze River Pharmaceutical Group Tegafur,Gimeracil and Oteracil Porassium Capsules Product and Services
- 2.5.4 Yangtze River Pharmaceutical Group Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Yangtze River Pharmaceutical Group Recent Developments/Updates
3 Competitive Environment: Tegafur,Gimeracil and Oteracil Porassium Capsules by Manufacturer
- 3.1 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue by Manufacturer (2021-2026)
- 3.3 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Tegafur,Gimeracil and Oteracil Porassium Capsules by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Tegafur,Gimeracil and Oteracil Porassium Capsules Manufacturer Market Share in 2025
- 3.4.3 Top 6 Tegafur,Gimeracil and Oteracil Porassium Capsules Manufacturer Market Share in 2025
- 3.5 Tegafur,Gimeracil and Oteracil Porassium Capsules Market: Overall Company Footprint Analysis
- 3.5.1 Tegafur,Gimeracil and Oteracil Porassium Capsules Market: Region Footprint
- 3.5.2 Tegafur,Gimeracil and Oteracil Porassium Capsules Market: Company Product Type Footprint
- 3.5.3 Tegafur,Gimeracil and Oteracil Porassium Capsules Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Market Size by Region
- 4.1.1 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Quantity by Region (2021-2032)
- 4.1.2 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Consumption Value by Region (2021-2032)
- 4.1.3 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Average Price by Region (2021-2032)
- 4.2 North America Tegafur,Gimeracil and Oteracil Porassium Capsules Consumption Value (2021-2032)
- 4.3 Europe Tegafur,Gimeracil and Oteracil Porassium Capsules Consumption Value (2021-2032)
- 4.4 Asia-Pacific Tegafur,Gimeracil and Oteracil Porassium Capsules Consumption Value (2021-2032)
- 4.5 South America Tegafur,Gimeracil and Oteracil Porassium Capsules Consumption Value (2021-2032)
- 4.6 Middle East & Africa Tegafur,Gimeracil and Oteracil Porassium Capsules Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Quantity by Type (2021-2032)
- 5.2 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Consumption Value by Type (2021-2032)
- 5.3 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Average Price by Type (2021-2032)
6 Market Segment by Channel
- 6.1 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Quantity by Channel (2021-2032)
- 6.2 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Consumption Value by Channel (2021-2032)
- 6.3 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Average Price by Channel (2021-2032)
7 North America
- 7.1 North America Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Quantity by Type (2021-2032)
- 7.2 North America Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Quantity by Channel (2021-2032)
- 7.3 North America Tegafur,Gimeracil and Oteracil Porassium Capsules Market Size by Country
- 7.3.1 North America Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Quantity by Country (2021-2032)
- 7.3.2 North America Tegafur,Gimeracil and Oteracil Porassium Capsules Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Quantity by Type (2021-2032)
- 8.2 Europe Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Quantity by Channel (2021-2032)
- 8.3 Europe Tegafur,Gimeracil and Oteracil Porassium Capsules Market Size by Country
- 8.3.1 Europe Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Tegafur,Gimeracil and Oteracil Porassium Capsules Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Quantity by Channel (2021-2032)
- 9.3 Asia-Pacific Tegafur,Gimeracil and Oteracil Porassium Capsules Market Size by Region
- 9.3.1 Asia-Pacific Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Tegafur,Gimeracil and Oteracil Porassium Capsules Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Quantity by Type (2021-2032)
- 10.2 South America Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Quantity by Channel (2021-2032)
- 10.3 South America Tegafur,Gimeracil and Oteracil Porassium Capsules Market Size by Country
- 10.3.1 South America Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Quantity by Country (2021-2032)
- 10.3.2 South America Tegafur,Gimeracil and Oteracil Porassium Capsules Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Quantity by Channel (2021-2032)
- 11.3 Middle East & Africa Tegafur,Gimeracil and Oteracil Porassium Capsules Market Size by Country
- 11.3.1 Middle East & Africa Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Tegafur,Gimeracil and Oteracil Porassium Capsules Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Tegafur,Gimeracil and Oteracil Porassium Capsules Market Drivers
- 12.2 Tegafur,Gimeracil and Oteracil Porassium Capsules Market Restraints
- 12.3 Tegafur,Gimeracil and Oteracil Porassium Capsules Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Tegafur,Gimeracil and Oteracil Porassium Capsules and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Tegafur,Gimeracil and Oteracil Porassium Capsules
- 13.3 Tegafur,Gimeracil and Oteracil Porassium Capsules Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Tegafur,Gimeracil and Oteracil Porassium Capsules Typical Distributors
- 14.3 Tegafur,Gimeracil and Oteracil Porassium Capsules Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Tegafur,Gimeracil and Oteracil Porassium Capsules. Industry analysis & Market Report on Tegafur,Gimeracil and Oteracil Porassium Capsules is a syndicated market report, published as Global Tegafur,Gimeracil and Oteracil Porassium Capsules Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Tegafur,Gimeracil and Oteracil Porassium Capsules market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
